Table 4.
SAR of meta aniline ring substitutions
![]() | |||||
---|---|---|---|---|---|
Compound | R2 | R4 | Tb IC50,b μM | Hs IC50,c μM | Tb427 EC50,d μM |
7 | Cl | Cl | 3.7 (3.3–4.1) | 27% at 180 | 5.6 (4.5–7.1) |
32 | Br | Cl | 2.2 (2.0–2.4) | 33% at 180 | 4.7 (3.9–5.8) |
33 | CN | Cl | 3.9 (3.2–4.8) | 29% at 180 | 12 (10–14) |
34 | CF3 | Cl | 3.9 (3.4–4.4) | 39% at 180 | 13 (11–15) |
35 | Ph | Cl | 3.3 (2.8–3.9) | 30% at 63 | 4.5 (2.1–9.4) |
36 | SF5 | Cl | 16 (14–18) | >180 | 13 (11–15) |
37 | SF5 | Br | 8.7 (7.4–10) | >180 | 0.45 (0.32–0.62) |
38 | Et | Br | 7.6 (5.7–10) | >180 | 5.5 (4.6–6.6) |
39 | OEt | Br | 6.0 (5.2–6.9) | 36% at 180 | 4.4 (4.2–4.7) |
40 | OCH2CF3 | Br | 1.6 (1.1–2.4) | 44 | 4.2 (3.6–4.8) |
41 | OCH2CHCH2 | Br | 4.5 (4.1–4.9) | 28% at 180 | 4.4 (3.7–5.3) |
42 | OBu | Br | 4.5 (4.0–5.1) | >180 | 1.9 (1.7–2.1) |
43 | OCH2iPr | Br | 11 (9.5–12) | >180 | 4.4 (3.5–5.5) |
44 | Br | Br | 1.9 (1.7–2.1) | 31% at 180 | 4.8 (4.1–5.6) |
45 | SO2Me | SO2Me | 1.5 (1.3–1.7) | 39% at 180 | >100 |
46 | CF3 | CF3 | 11 (9.8–12) | >180 | 14 (11–17) |
47 | OMe | OMe | 17 (14–20) | 21% at 180 | 41 (33–51) |
48 | CO2H | CO2H | >180 | >180 | >100 |
49 | CO2Me | CO2Me | 40% at 180 | >180 | 42 (22–78) |
50 | Ph | Ph | >180 | >180 | 1.5 (1.3–1.6) |
51 | N-(3,5-Cl2Ph)−acetamide | N-(3,5-Cl2Ph)−acetamide | >180 | >180 | 2.0 (1.2–3.7) |
52 | Me | Me | 141 (119–167) | >180 | 19 (17–22) |
53 | tBu | tBu | >63 | >63 | 4.1 (4.1–4.5) |
54 | SF5 | H | 23% at 180 | >180 | 14 (11–17) |
55 | Cl | H | 35% at 180 | >180 | 42 (34–52) |
56 | Br | H | 41% at 180 | >180 | 22 (19–26) |
57 | F | H | >180 | >180 | >25 |
58 | SMe | H | 149 (122–181) | 23% at 180 | >25 |
59 | H | H | >180 | >180 | >25 |
60 | F | F | 180 (160–201) | >180 | 70 (61–80) |
61 | F | Cl | 32 (13–82) | >180 | 17 (15–20) |
All compounds have pKa(N1)a of 7.3.
See footnotes for Table 1.